fluorexon has been researched along with Cancer of Ovary in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrieu, T; Boumendjel, A; Comsa, E; Falson, P; Loghin, F; Nguyen, KA; Peuchmaur, M | 1 |
| Ando, M; Bai, L; Bai, Y; Hasegawa, R; Hasegawa, T; Hirose, K; Kataoka, T; Ogura, H; Sakai, J; Toki, A; Zhao, M | 1 |
2 other study(ies) available for fluorexon and Cancer of Ovary
| Article | Year |
|---|---|
Ovarian cancer cells cisplatin sensitization agents selected by mass cytometry target ABCC2 inhibition.
Topics: Antineoplastic Agents; Benzofurans; Cell Line, Tumor; Cell Survival; Cisplatin; Drug Resistance, Neoplasm; Female; Fluoresceins; Humans; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Ovarian Neoplasms | 2018 |
The structure of a new cardenolide diglycoside and the biological activities of eleven cardenolide diglycosides from Nerium oleander.
Topics: Anti-Inflammatory Agents; Antineoplastic Agents, Phytogenic; Cardenolides; Cell Line, Tumor; Drug Resistance, Neoplasm; Female; Fluoresceins; Humans; Magnetic Resonance Spectroscopy; Molecular Conformation; Nerium; Ovarian Neoplasms | 2011 |